Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Drug Metabolism and Pharmacokinetics|January 16, 2007
Allele and genotype frequency of MDR1 C3435T in Tamilian populationKesavan Ramasamy, Soya Sisy Sam, Adithan ChandrasekaranJournal of Biomolecular Structure & Dynamics|May 13, 2023
Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human POR gene: a structural and functional impactRajalakshmi Kumar, Manikandan Jayaraman, Krishna Ramadas, et al.Journal of Pharmacology & Pharmacotherapeutics|November 26, 2014
Oyster shell calcium induced parotid swellingMuthiah Palaniappan, Sandhiya Selvarajan, Sureshkumar Srinivasamurthy, et al.Journal of Molecular Graphics & Modelling|August 18, 2020
Insight into the structural and functional analysis of the impact of missense mutation on cytochrome P450 oxidoreductaseRajalakshmi Kumar, Manikandan Jayaraman, Krishna Ramadas, et al.Journal of Clinical and Diagnostic Research : JCDR|December 6, 2014
Anticancer drug induced palmar plantar erythrodysesthesiaMuthiah Palaniappan, Sureshkumar Srinivasamurthy, Biswajit Dubashi, et al.Neurology India|November 28, 2007
Severe phenytoin toxicity in a CYP2C9*3*3 homozygous mutant from IndiaKesavan Ramasamy, Sunil K Narayan, Shashindran Chanolean, et al.Psychiatry Research|April 26, 2016
Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophreniaAlladi Charan, Deepak Gopal Shewade, Ravi Philip Rajkumar, et al.Therapeutic Drug Monitoring|November 12, 2010
Influence of CYP2C9 genetic polymorphism and undernourishment on plasma-free phenytoin concentrations in epileptic patientsKesavan Ramasamy, Sunil K Narayan, Deepak Gopal Shewade, et al.European Journal of Clinical Pharmacology|April 22, 2016
Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian populationManu Jose, Jayanthi Mathaiyan, Shivanand Kattimani, et al.Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance studyJose Francis, Muthiah Palaniappan, Biswajit Dubashi, et al.Pageof 4